Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The effort will leverage the NVIDIA Artificial Intelligence (AI) platform and Thermo Fisher Scientific solutions to progressively increase the automation, accuracy and speed of laboratories. The companies are working together to evolve the digital foundation that powers scientific instruments, laboratory infrastructure and data -- connecting them to powerful AI solutions, helping scientists reduce manual steps and accelerate scientific advancement.

Accelerating smarter, connected scientific workflows and laboratories

In most laboratories today, scientists still perform many tasks manually—from designing experiments and setting up instrumentation to preparing samples, running instruments, and interpreting results. The collaboration between Thermo Fisher and NVIDIA will meaningfully contribute to modernizing these processes; powering instruments with better AI capabilities, connecting laboratories and data to AI software, and augmenting scientists’ capabilities to design, perform and analyze data from their experiments.

Thermo Fisher will pair its expertise in scientific instruments and lab software with NVIDIA’s AI Infrastructure—including NVIDIA DGX Spark, the supercomputer for your desktop and models, such as NVIDIA NeMo and NVIDIA BioNeMo to evolve scientific instrumentation to interact with scientists seamlessly with an intuitive user experience that helps democratize the next generation of scientific discovery.

“Artificial intelligence coupled with laboratory automation will transform how scientific work is performed,” said Gianluca Pettiti, Executive Vice President. “By combining Thermo Fisher’s leadership in laboratory technologies with NVIDIA’s digital and AI solutions, we can help customers work faster, improve accuracy and get more value out of each experiment, ultimately accelerating discoveries that can have significant human impact.”

“We are entering the era of ‘lab-in-the-loop’ science where the trinity of AI, agents and instruments will be able to scale scientific discovery at industrial pace,” said Kimberly Powell, Vice President of Healthcare at NVIDIA. “Working with Thermo Fisher, we are building the fundamental infrastructure of autonomous labs, creating a powerful research and discovery flywheel accelerating the pace of life sciences breakthroughs.”